Completed

Etiology and Treatment of Alcohol Dependence

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

acamprosate (Campral)

Drug
Who is being recruted

Mental Disorders+2

+ Substance-Related Disorders

+ Alcohol-Related Disorders

From 21 to 55 Years
+18 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 2
Interventional
See protocol details

Summary

Principal SponsorYale University
Last updated: July 2, 2015
Sourced from a government-validated database.Claim as a partner

This study will examine whether pretreatment with two doses of acamprosate for seven days prior to abstinence lessens the intensity of acute withdrawal from alcohol compared with a placebo. Subjects will be randomly assigned to receive either one of two doses of acamprosate or placebo for seven days. This will be followed by a four- day inpatient period when withdrawal will be monitored. Additional drinking information will be obtained at a three month followup interview.

NCT00004552
Principal SponsorYale University
Last updated: July 2, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

120 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 21 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersSubstance-Related DisordersAlcohol-Related DisordersChemically-Induced DisordersAlcoholism

Criteria

4 inclusion criteria required to participate
Able to read English at 6th grade level or higher and to complete study evaluations

Average weekly alcohol consumption of standard drinks of at least 25 drinks for men and 20 drinks for women

Meets criteria for alcohol abuse or dependence

No more than 3 days abstinence/week

14 exclusion criteria prevent from participating
Alcohol withdrawal symptoms requiring management with benzodiazepines

Current abuse or dependence on other substances, other than nicotine and marijuana

Females who are pregnant, nursing or not using a reliable method of birth control

Hepatocellular disease or a history of cirrhosis

Show More Criteria

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Substance Abuse Treatment Unit, University of Connecticut

New Haven, United StatesOpen Substance Abuse Treatment Unit, University of Connecticut in Google Maps
CompletedOne Study Center